|
Home
Gamma Knife Performed Hydrocephalus Gamma Knife Explained Constant Dizziness and Acoustic Neuroma Don't Let Your Kids Use Mobile Phones Acoustic Neuroma Picture Symptoms and Anatomy of Acoustic Neuromas Signs of Acoustic Neuroma A Randomized Controlled Trial Tinnitus Pronunciation Symptoms of Acoustic Neuroma Symptoms Vestibular schwannoma with contralateral facial pain - case report Messageboard Treatment Feedback What is Acoustic Neuroma Dr. James Wong’s Radiation Treatment Site Map Top Web Sites
Surviving
Prostate Cancer Medical Sites -
Genitourinary ProstatitisAndBPH.org How we made this site
|
Delta-aminolevulinic Acid dehydratase polymorphism and risk of brain tumors inRajaraman P, Schwartz BS, Rothman N, Yeager M, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PDEnviron Health Perspect. 2005 Sep;113(9):1209-11.. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. rajarama@mail.nih.gov The enzyme delta-aminolevulinic acid dehydratase (ALAD), which catalyzes the second step of heme synthesis, can be inhibited by several chemicals, including lead, a potential risk factor for brain tumors, particularly meningioma. In this study we examined whether the ALAD G177C polymorphism in the gene coding for ALAD is associated with risk of intracranial tumors of the brain and nervous system. We use data from a case-control study with 782 incident brain tumor cases and 799 controls frequency matched on hospital, age, sex, race/ethnicity, and residential proximity to the hospital. Blood samples were drawn and DNA subsequently sent for genotyping for 73% of subjects. ALAD genotype was determined for 94% of these samples (355 glioma, 151 meningioma, 67 acoustic neuroma, and 505 controls). Having one or more copy of the ALAD2 allele was associated with increased risk for meningioma [odds ratio (OR) = 1.6; 95% confidence interval (CI), 1.0-2.6], with the association appearing stronger in males (OR = 3.5; 95% CI, 1.3-9.2) than in females (OR = 1.2; 95% CI, 0.7-2.2). No increased risk associated with the ALAD2 variant was observed for glioma or acoustic neuroma. These findings suggest that the ALAD2 allele may increase genetic susceptibility to meningioma.< This abstract is being posted for educational purposes, as well as for comment and criticism, by the visitors to the Acoustic Neuroma Foundation website. This abstract is representative of a larger article that is indexed on Medline. Men's Health Web RingSurvivingProstateCancerWithoutSurgery.org VasectomyFoundation.org Prostatitis Foundation ( Prostatitis.org) Disclaimer: Information provided on this web site is for educatonal purposes only. It is not a substitute for, nor can it replace advice from your own physician. The information on this site is not to be used for diagnosing or treating any health concerns that you may have. You must see your own physician for diagnosis and treatment. Furthermore, the information on this site is never guaranteed to be 100% accurate or 100% up to date. All the side effects of mentioned treatments, drugs, surgeries, or therapies cannot always be listed or be known. Errors and omissions may occur in any essay. See a competent physician for your health care needs. http://www.acousticneuromafoundation.org™ Established December 11, 2002 |
|